ReFleks

Regenerative medicine for fixing joint damage to stop osteoarthritis

Prof Francesco Dell'Accio

Professor of Musculoskeletal Regenerative Medicine and Rheumatology

Dr Suzanne Eldridge

Senior Lecturer of Musculoskeletal Regenerative Medicine

ReFleks have developed a new way to repair cartilage damage – commonly caused by sports injuries or trauma – to restore joint function and to prevent progression to osteoarthritis.

The method – a simple injection – is substantially cheaper and significantly easier to administer than even the best of today’s approaches – making it more viable for healthcare providers. Their invention paves the way for a future regenerative treatment for osteoarthritis.

The market is big and growing – and ReFleks are well-positioned to take a significant portion of it.

Hear from the inventors at BioTrinity2025.

More Queen Mary spinouts

Keratify: A more effective way to maintain skin in culture

Kinomica: A diagnostic platform for precision medicine

hVIVO: Testing infectious and respiratory products